You just read:

Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease

News provided by

Aspen Neuroscience

Dec 12, 2019, 06:00 ET